Fig. 2: Viral loads and virus titres in BAL fluid and lung lobes.
From: Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

a, b, Viral loads (a) and infectious virus titres in BAL (b) collected from rhesus macaques infected with SARS-CoV-2 and treated with remdesivir (n = 6) or vehicle solution (n = 6). TCID50, 50% tissue culture infectious dose. Statistical analysis was performed using a two-way ANOVA with Sidak’s multiple comparisons test. c, Viral loads in tissues collected from all six lung lobes at necropsy on 7 dpi from rhesus macaques infected with SARS-CoV-2 and treated with remdesivir (n = 6) or vehicle solution (n = 6). Statistical analysis was performed using an unpaired t-test. Centre bars, median.